Abstract:
본 발명은 혈관신생(angiogenesis) 억제 활성을 가지는 소목 추출물 및 이로부터 분리된 화합물의 용도에 관한 것으로서, 보다 상세하게는 물, 알콜 또는 이들의 혼합물로 추출되는 추출물, 상기 추출물로부터 분리한 브라질린, 사판칼콘, 브라질레인의 혈관신생 억제 용도에 관한 것이다. 본 발명의 소목 추출물 및 이로부터 분리된 화합물은 혈관신생을 억제하는 활성을 가지므로, 혈관 질환, 심혈관계 질환, 안과 질환, 만성 염증성 질환, 피부과 질환, 알츠하이머, 비만 및 암 등의 혈관 신생 관련 질환의 예방 또는 치료에 유용하게 사용될 수 있다. 혈관신생, 소목, 브라질린, 사판칼콘, 브라질레인, 관절염, 당뇨병성 망막증, 건선, 암
Abstract:
본 발명은 T-형 칼슘 채널에 대한 활성을 갖는 2-(4-치환-1,4-디아제판-1-일)아세트아마이드 화합물, 상기 화합물의 제조방법, 그리고 상기 화합물을 유효성분으로 포함하는 약학조성물에 관한 것이다. 본 발명의 신규 2-(4-치환-1,4-디아제판-1-일)아세트아마이드 화합물 또는 약학적으로 허용 가능한 이의 염은 T-형 칼슘 채널에 대한 길항작용을 가지므로 간질, 고혈압 등의 뇌질환 치료제, 협심증 등의 심장질환 치료제, 만성 통증, 신경성 통증 등의 통증질환 치료제, 또는 항암제로 유용하다.
Abstract:
본 발명은 T-형 칼슘 채널에 대한 활성을 갖는 1-(4-치환-1,4-디아제판-1-일)에탄온 화합물, 상기 화합물의 제조방법, 그리고 상기 화합물을 유효성분으로 포함하는 약학조성물에 관한 것이다. 본 발명의 신규 1-(4-치환-1,4-디아제판-1-일)에탄온 화합물 또는 약학적으로 허용 가능한 이의 염은 T-형 칼슘 채널에 대한 길항작용을 가지므로 간질, 고혈압 등의 뇌질환 치료제, 협심증 등의 심장질환 치료제, 만성 통증, 신경성 통증 등의 통증질환 치료제, 또는 항암제로 유용하다.
Abstract:
PURPOSE: A diphenylpropanoyl compound having T-type calcium channel activity is provided to ensure antagonism to a T-type calcium channel and to be used as a therapeutic agent and anticancer agent. CONSTITUTION: A diphenylpropanoyl is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating hypertension, angina, chronic pain, neurogenic pain or cancer contains a compound of chemical formula 1 as an active ingredient. A method for preparing the compound of chemical formula 1 comprises a step of binding a compound of chemical formula 2 with a compound of chemical formula 3.
Abstract:
Use of the extract of Caesalpinia sappan L. and compounds isolated therefrom is provided to prevent and treat diseases associated with angiogenesis including vascular disease, cardiovascular disease, eye disease, chronic inflammatory disease, skin disease, Alzheimer's disease, obesity and cancer by inhibiting angiogenesis. The extract of Caesalpinia sappan L. is obtained by extracting Caesalpinia sappan L. with water, alcohol or a mixture thereof, and contains brazilin, sappanchalcone and brazilein as active ingredients, wherein the alcohol is C1-C3 lower alcohol. A composition for inhibiting angiogenesis comprises the extract of Caesalpinia sappan L. or at least one compound isolated therefrom selected from brazilin, sappanchalcone and brazilein.
Abstract:
A mass production method of brazilein from Caesalpinia sappan L. is provided to reduce the time and costs for production of brazilein and obtain high purity of brazilein by eliminating a process of column chromatography and using no expensive chromatography devices, so that the brazilein is produced in the industrial scale. The mass production method of brazilein from Caesalpinia sappan L. comprises the steps of: (1) extracting Caesalpinia sappan L. with water, alcohol or a mixture thereof; (2) concentrating the extract of Caesalpinia sappan L. to obtain crude crystals of Caesalpinia sappan L.; (3) dissolving the crude crystals in alcohol; (4) concentrating the solution of step(3) in a water bath at 30-40 deg.C and 40-180 rpm; and (5) recrystallizing the concentrated solution by evaporating the solution at 15-30 deg.C for 6-72 hours, wherein the alcohol of the steps(1) and (3) is C1-C3 lower alcohol such as methanol; and the alcohol temperature of step(3) is the of 40-64 deg.C.
Abstract:
PURPOSE: A pharmaceutical composition containing pyrazoyl piperidine compounds and pharmaceutically acceptable salt thereof is provided to prevent or treat brain diseases, heard diseases, cancer, and pain. CONSTITUTION: A pyrazoyl piperidine compound is denoted by chemical formula 1. A pharmaceutical composition for treating cerebral diseases, cardiac diseases, cancer, or pain contains the compound of chemical formula 1 as an active ingredient. A method for preparing the compound comprises: a step of reacting piperidine acetate of chemical formula 2 and pyrazole methyl amine of chemical formula 3 of a step of reacting piperidine compound of chemical formula 4 with an aldehyde compound of chemical formula 5 by reduction-amination. [Reference numerals] (AA) Reductive amination
Abstract:
PURPOSE: A method for controlling a self-assembled structure of poly(3-hexylthiophene)-based block copolymer is provided to control the self-assembled structure of poly(3-hexylthiophene)-based block copolymer by only simple process of coating a polymer composition consisting of a poly(3-hexylthiophene)-based block copolymer and a solvent on a substrate. CONSTITUTION: A method for controlling a self-assembled structure of poly(3-hexylthiophene)-based block copolymer comprises the steps of: preparing a polymer composition including a solvent and a block copolymer in which a non-conjugated polymer is introduced to a π-conjugated poly(3-hexylthiophene) polymer; and applying the polymer composition to a substrate.